Case no. | Age/Sex | Karyotype of five-way translocation | Reference no. | Treatment | Outcome |
---|---|---|---|---|---|
1 | 10/Male | t(4;18;13;9;22)(q12;q11.2;q14;q34;q11.2) | [1] | BSF | Died 81months |
2 | 23/Male | t(9;22;15;19;10) | [2] | Not reported | Not reported |
3 | 68/Not reported | t(3;4;9;11;22) | [3] | Not reported | Died in benign phase |
4 | 64/Female | t(9;22;21;11;inv ins(12)(q15p12p13)(q34;q11;q22;q13;q15) | [4] | BSF/VCR and PSL/ADM, CPA and MTX | Died 33 months |
5 | 63/Male | t(9;22;10;12;1)(q34;q11.2;q22;p12;p36.1) | [5] | DNR,VCR,AND and PSL | Died 34 months |
6 | 68/Female | t(9;22;15;13;17)(q34;q11;q26;q14;q11) | [6] | Chemotherapy | Not reported |
7 | Not reported/Male | t(2;9;16;22;22)(q32;q34;q21;q11;q11) | [7] | Not reported | Not reported |
8 | 32/Male | t(4;12;7;9;22)(q33?;q24;p13;q34;q11) | [8] | GLI | 41 months |
9 | 45/Female | t(1;4;5;9;22)(q42;p14;q31;q34;q11.2) | [9] | HU/GLI | 62 months |
10 | 58/Male | t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) | The present case | GLI | 44 months |